Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q7455039> ?p ?o }
Showing triples 1 to 18 of
18
with 100 triples per page.
- Q7455039 subject Q7404119.
- Q7455039 subject Q8639167.
- Q7455039 abstract "Serostim (recombinant DNA somatropin) is Serono's brand name prescription drug form of synthetic growth hormone, marketed for AIDS wasting.In December 2007, the U.S. District Court of Massachusetts settled a class-action lawsuit that involved Merck Serono and the drug Serostim. The lawsuit claims that Merck Serono encouraged doctors to prescribe Serostim off-label for criteria that were not approved by the FDA. Merck Serono denies these claims and any liability. However, Merck Serono has entered into a settlement "solely to avoid the further expense, inconvenience, burden, and uncertainty of these lawsuits."The settlement will pay consumers of Serostim who paid the full cash amount or a co-payment as part of their medical treatment.".
- Q7455039 wikiPageExternalLink www.serostimsettlement.com.
- Q7455039 wikiPageWikiLink Q119697.
- Q7455039 wikiPageWikiLink Q12199.
- Q7455039 wikiPageWikiLink Q15221048.
- Q7455039 wikiPageWikiLink Q1643563.
- Q7455039 wikiPageWikiLink Q190199.
- Q7455039 wikiPageWikiLink Q2779401.
- Q7455039 wikiPageWikiLink Q2783852.
- Q7455039 wikiPageWikiLink Q285697.
- Q7455039 wikiPageWikiLink Q431289.
- Q7455039 wikiPageWikiLink Q669903.
- Q7455039 wikiPageWikiLink Q7404119.
- Q7455039 wikiPageWikiLink Q8639167.
- Q7455039 comment "Serostim (recombinant DNA somatropin) is Serono's brand name prescription drug form of synthetic growth hormone, marketed for AIDS wasting.In December 2007, the U.S. District Court of Massachusetts settled a class-action lawsuit that involved Merck Serono and the drug Serostim. The lawsuit claims that Merck Serono encouraged doctors to prescribe Serostim off-label for criteria that were not approved by the FDA. Merck Serono denies these claims and any liability.".
- Q7455039 label "Serostim".